澳门大阳城122.ccapp官方下载

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

CD55 is a key complement regulatory protein that counteracts complement-mediated inactivation of Newcastle Disease Virus.

J. Gen. Virol.. 2016-10; 
RangaswamyUdaya S,CotterChristopher R,ChengXing,JinHong,ChenZhong
Products/Services Used Details Operation
Gene Synthesis … genes. The cDNAs encoding human CD55 (GenBank accession no. NM000574) and human CD59 (NM203330) were pur- chased from Origene, and the cDNA for human CD46 (NM002389) was synthesized by Genscript. Each … Get A Quote

摘要

Newcastle disease virus (NDV) is being developed as an oncolytic virus for virotherapy. In this study we analysed the regulation of complement-mediated inactivation of a recombinant NDV in different host cells. NDV grown in human cells was less sensitive to complement-mediated virus inactivation than NDV grown in embryonated chicken eggs. Additionally, NDV produced from HeLa-S3 cells is more resistant to complement than NDV from 293F cells, which correlated with higher expression and incorporation of complement regulatory proteins (CD46, CD55 and CD59) into virions from HeLa-S3 cells. Further analysis of the recombinant NDVs individually expressing the three CD molecules showed that CD55 is the most poten... More

关键词